Gilead Sciences, Inc. · NASDAQ:GILD
Dickinson Andrew D sold 3,000 Gilead Sciences, Inc. shares (Form 4)
Traded Oct 15, 2026 · Filed Oct 16, 2026
On Oct 15, 2026, Dickinson Andrew D (Chief Financial Officer) sold 3,000 Gilead Sciences, Inc. shares at US$156.22 for US$469K under a trading plan, leaving 161,096 shares. Filed Oct 16, 2026 (Form 4).
- Sold
- 3,000 shares
- Price
- US$156.22
- Value
- US$469K
- Holding after
- 161,096 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Chief Financial Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Oct 15, 2026 | Common Stock | Sale | 3,000 | US$156.22 | 161,096 | Direct |
Source
Download original · View original at SEC
Related
- Gilead Sciences, Inc.
- Dickinson Andrew D
- Gilead Sciences, Inc. shareholders
- Form 4 · Dickinson Andrew D · Sep 16, 2026
- Form 4 · Dickinson Andrew D · Sep 11, 2026
- Form 4 · Dickinson Andrew D · Aug 18, 2026
- Form 4 · Dickinson Andrew D · Jul 16, 2026
- Form 4 · Dickinson Andrew D · Jun 16, 2026
- Form 4 · Mercier Johanna · Oct 16, 2026
- Form 4 · O'Day Daniel Patrick · Oct 2, 2026
- Form 4 · Burkhart Erin · Sep 23, 2026
- Form 4 · Mercier Johanna · Sep 16, 2026
- Form 4 · Mercier Johanna · Sep 11, 2026